These data do not exclude a contribution of systemic inflammatory factors, such as serum cytokines and C-reactive protein previously shown to be increased in atherosclerosis [45], [47], but suggest that the atherogenic effects of FcγR are mainly mediated via inflamed cells localized in plaques. The gene discussed is CRP; the disease is atherosclerosis.